Published :
Tables : 19
Figures : 31
Category : Healthcare
No. of Pages : 230
Report Code : HC-1047
Clinical Trials Imaging Techniques Market Introduction: A clinical trial is a prospective research study which tests a new treatment or novel way of using existing treatment to see if it will be a better way to prevent or treat and screen for diagnose or treat a disease. During these study volunteers (research subjects either humans or animals) will undergo various imaging techniques to see the effect of novel drug /treatment on disease part of interest. Presently various imaging techniques are emerging to gain the metabolic and functional information from the molecular level. So, imaging has a specific central role in evaluating the impact of devices and drugs in clinical trials. Imaging technologies have rapidly gained traction over the past decades due to increasing clinical trial applications. Traction is further gained by increasing the number of clinical trials due to increasing R&D investments led to robust growth of global clinical trials imaging techniques market. Imaging techniques have a wide range of applications in assessing treatment response for medical interventions. Additionally, they also offer metabolic and functional information through molecular imaging techniques. All these factors led to the potential growth of clinical trial imaging techniques market. Molecular imaging also provides treatment follow-up information and decreases medical errors during the clinical trials. These features led to increasing applicability of imaging techniques in clinical trials and boosted the growth of the market. Global Oncology information system market is dominated by North America and Europe due to high capital investment in research. Further, they are expected to remain dominant throughout the forecast period. Asia Pacific is expected to register a fast growth rate during the forecast period due to an increase in R&D activities. Latin America and Rest of World Clinical Trials Imaging Techniques market is expected to remain slow-growing regions due to lack of R&D investments Clinical Trials Imaging Techniques market players include: GE Healthcare, Siemens Healthcare, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others. Clinical Trials Imaging Market Segmentation: By Imaging Type CT MRI PET Ultrasound Echocardiography X-Ray By End User Biopharmaceutical Companies Contract Research Organization Academic Institutes Hospitals Medical Device Manufactures Others (cosmetics and skin care companies) By Region Europe North America APAC Latin America Rest of World Competitive Landscape: Tier 1 players- established companies in the market with a major market share Tier 2 players Emerging players which are growing rapidly New Entrants FutureWise Takeaways Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on global clinical trials imaging market by imaging type, end-user and region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies
A clinical trial is a prospective research study which tests a new treatment or novel way of using existing treatment to see if it will be a better way to prevent or treat and screen for diagnose or treat a disease. During these study volunteers (research subjects either humans or animals) will undergo various imaging techniques to see the effect of novel drug /treatment on disease part of interest. Presently various imaging techniques are emerging to gain the metabolic and functional information from the molecular level. So, imaging has a specific central role in evaluating the impact of devices and drugs in clinical trials.
Imaging technologies have rapidly gained traction over the past decades due to increasing clinical trial applications. Traction is further gained by increasing the number of clinical trials due to increasing R&D investments led to robust growth of global clinical trials imaging techniques market. Imaging techniques have a wide range of applications in assessing treatment response for medical interventions. Additionally, they also offer metabolic and functional information through molecular imaging techniques. All these factors led to the potential growth of clinical trial imaging techniques market. Molecular imaging also provides treatment follow-up information and decreases medical errors during the clinical trials. These features led to increasing applicability of imaging techniques in clinical trials and boosted the growth of the market.
Global Oncology information system market is dominated by North America and Europe due to high capital investment in research. Further, they are expected to remain dominant throughout the forecast period. Asia Pacific is expected to register a fast growth rate during the forecast period due to an increase in R&D activities. Latin America and Rest of World Clinical Trials Imaging Techniques market is expected to remain slow-growing regions due to lack of R&D investments
Clinical Trials Imaging Techniques market players include:
GE Healthcare, Siemens Healthcare, Philips Healthcare, Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Hitachi Medical Corporation and others.
Clinical Trials Imaging Market Segmentation:
By Imaging Type
By End User
By Region
Competitive Landscape:
FutureWise Takeaways
Objectives of the Study:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Clinical Trials Imaging Techniques Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global Clinical Trials Imaging Techniques Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Clinical Trials Imaging Techniques Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Clinical Trials Imaging Techniques Market, By Imaging Type Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. CT 7.2. MRI 7.3. PET 7.4. Ultrasound 7.5. Echocardiography 7.6. X-Ray 8. Global Clinical Trials Imaging Techniques Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Biopharmaceutical Companies 8.2. Contract Research Organization 8.3. Academic Institutes 8.4. Hospitals 8.5. Medical Device Manufactures 8.6. Others (cosmetics and skin care companies) 9. North America Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 9.2.1. U.S.A 9.2.2. Canada 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Europe Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.8. Switzerland 10.2.9.Rest of Western Europe 11. Asia Pacific Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Japan 11.2.2. China 11.2.3. Singapore 11.2.4. India 11.2.5. Australia and New Zealand 11.2.6. ASEAN 11.2.7. South Korea 11.2.8. Rest of Asia Pacific 11.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 12. Middle East and Africa Skin Perfusion Pressure Testing Device Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Saudi Arabia 12.2.2. UAE 12.2.3. South Africa 12.2.4. Egypt 12.3. Market Size (USD Million) Forecast for MEA 2020-2027 13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 13.1. GE Healthcare 13.1.1. Company Overview 13.1.2. Product Portfolio 13.1.3. SWOT Analysis 13.1.4. Financial Overview 13.1.5. Strategic Overview 13.2. Siemens Healthcare 13.2.1. Company Overview 13.2.2. Product Portfolio 13.2.3. SWOT Analysis 13.2.4. Financial Overview 13.2.5. Strategic Overview 13.3. Philips Healthcare 13.3.1. Company Overview 13.3.2. Product Portfolio 13.3.3. SWOT Analysis 13.3.4. Financial Overview 13.3.5. Strategic Overview 13.4. Shimadzu Corporation 13.4.1. Company Overview 13.4.2. Product Portfolio 13.4.3. SWOT Analysis 13.4.4. Financial Overview 13.4.5. Strategic Overview 13.5. Toshiba Medical Systems Corporation 13.5.1. Company Overview 13.5.2. Product Portfolio 13.5.3. SWOT Analysis 13.5.4. Financial Overview 13.5.5. Strategic Overview 13.6. Carestream Health 13.6.1. Company Overview 13.6.2. Product Portfolio 13.6.3. SWOT Analysis 13.6.4. Financial Overview 13.6.5. Strategic Overview 13.7. Hitachi Medical Corporation 13.7.1. Company Overview 13.7.2. Product Portfolio 13.7.3. SWOT Analysis 13.7.4. Financial Overview 13.7.5. Strategic Overview 14. FutureWise SME key takeaway points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Clinical Trials Imaging Techniques Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards And Compliances
5. Global Clinical Trials Imaging Techniques Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Clinical Trials Imaging Techniques Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Clinical Trials Imaging Techniques Market, By Imaging Type Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. CT
7.2. MRI
7.3. PET
7.4. Ultrasound
7.5. Echocardiography
7.6. X-Ray
8. Global Clinical Trials Imaging Techniques Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Biopharmaceutical Companies
8.2. Contract Research Organization
8.3. Academic Institutes
8.4. Hospitals
8.5. Medical Device Manufactures
8.6. Others (cosmetics and skin care companies)
9. North America Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
9.1. Introduction
9.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
9.2.1. U.S.A
9.2.2. Canada
9.3. Market Size (USD Million) Forecast for North America 2020-2027
10. Europe Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.2.1. Germany
10.2.2. U.K
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Russia
10.2.7. Poland
10.2.8. Switzerland
10.2.9.Rest of Western Europe
11. Asia Pacific Clinical Trials Imaging Techniques Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.2.1. Japan
11.2.2. China
11.2.3. Singapore
11.2.4. India
11.2.5. Australia and New Zealand
11.2.6. ASEAN
11.2.7. South Korea
11.2.8. Rest of Asia Pacific
11.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
12. Middle East and Africa Skin Perfusion Pressure Testing Device Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Saudi Arabia
12.2.2. UAE
12.2.3. South Africa
12.2.4. Egypt
12.3. Market Size (USD Million) Forecast for MEA 2020-2027
13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Portfolio
13.1.3. SWOT Analysis
13.1.4. Financial Overview
13.1.5. Strategic Overview
13.2. Siemens Healthcare
13.2.1. Company Overview
13.2.2. Product Portfolio
13.2.3. SWOT Analysis
13.2.4. Financial Overview
13.2.5. Strategic Overview
13.3. Philips Healthcare
13.3.1. Company Overview
13.3.2. Product Portfolio
13.3.3. SWOT Analysis
13.3.4. Financial Overview
13.3.5. Strategic Overview
13.4. Shimadzu Corporation
13.4.1. Company Overview
13.4.2. Product Portfolio
13.4.3. SWOT Analysis
13.4.4. Financial Overview
13.4.5. Strategic Overview
13.5. Toshiba Medical Systems Corporation
13.5.1. Company Overview
13.5.2. Product Portfolio
13.5.3. SWOT Analysis
13.5.4. Financial Overview
13.5.5. Strategic Overview
13.6. Carestream Health
13.6.1. Company Overview
13.6.2. Product Portfolio
13.6.3. SWOT Analysis
13.6.4. Financial Overview
13.6.5. Strategic Overview
13.7. Hitachi Medical Corporation
13.7.1. Company Overview
13.7.2. Product Portfolio
13.7.3. SWOT Analysis
13.7.4. Financial Overview
13.7.5. Strategic Overview
14. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics